Clinical Trial Update: DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM [Phase 1]

View source ↗

Summary

This document summarizes a Phase 1 clinical trial update evaluating a DC/MM fusion vaccine in combination with BCMA-targeted CAR-T therapy for relapsed or refra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Or Refractory Multiple Myeloma

Drugs mentioned

• BCMA CAR-T
• DC/MM Fusion Vaccine (Dendritic cell–myeloma fusion vaccine)

Snippet

Sponsor: David Avigan | Conditions: Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | Status: NOT_YET_RECRUITING